Defective Breast Mesh, Acellular Dermal Matrix (ADM), and Bioabsorbable Scaffold Injury Attorneys in Rowlett: The Definitive Resource for Patients and Families
If you are a resident of Rowlett who has undergone breast reconstruction, revision, or augmentation and are now facing unexpected medical complications, we understand the fear and frustration you are feeling. Whether your surgery took place at a major surgical center in Dallas or a regional facility serving Rowlett, the realization that an implanted medical device—like acellular dermal matrix (ADM), a bioabsorbable scaffold, or surgical mesh—may be at the root of your pain is overwhelming. At Attorney911 (The Manginello Law Firm, PLLC), we provide compassionate legal guidance and aggressive advocacy for women in Rowlett. We are here to help you understand why these devices fail, what the FDA has said about their off-label use, and how you can seek the compensation you deserve for your injuries. Managing Partner Ralph Manginello, licensed by the State Bar of Texas (Bar Card No. 24007597) since 1998, brings twenty-seven years of practice experience to every case we handle in the Rowlett area.
Understanding the Devices: ADM, Scaffolds, and Mesh in Rowlett Breast Surgeries
In the world of Rowlett breast surgery, medical device manufacturers have marketed a variety of products designed to act as an “internal bra,” supporting tissue expanders or permanent implants. While these products are common in Rowlett operating rooms, most patients are surprised to learn that many were never specifically cleared or approved by the FDA for use in the breast envelope.
Acellular Dermal Matrix (ADM)
Acellular Dermal Matrix (ADM) is a biologic graft usually derived from human or animal skin tissue. Through a process of decellularization, the “cellular” components are removed, leaving a collagen scaffold meant to be repopulated by your own cells. Common brands used in Rowlett reconstructions include:
- AlloDerm and AlloDerm RTU (Allergan / AbbVie)
- Strattice Reconstructive Tissue Matrix (Allergan / AbbVie)
- FlexHD and FlexHD Pliable (MTF Biologics)
- AlloMax Surgical Graft (C.R. Bard / Becton Dickinson)
- SurgiMend (Integra LifeSciences)
Bioabsorbable and Resorbable Scaffolds
These are synthetic products designed to persist in the body for a fixed period—typically 12 to 24 months—before being absorbed through a process called hydrolysis. The most prominent material used currently is poly-4-hydroxybutyrate (P4HB). Residents of Rowlett may have been implanted with:
- GalaFLEX Scaffold (including GalaFLEX 3D, 3DR, and Lite versions)
- Phasix Mesh (often used off-label in Rowlett for breast support)
- DuraSorb Monofilament Mesh (composed of polydioxanone)
We have seen that when these devices fail, the physical and emotional toll on Rowlett patients is immense. If you’re questioning the safety of a device used in your surgery, call us at 1-888-ATTY-911 for a confidential case evaluation.
The FDA Regulatory Failure: “Predicate Creep” and Rowlett Patients
Most medical devices used in Rowlett surgeries enter the market through the FDA’s 510(k) clearance pathway. Under 21 USC §360c and 21 CFR Part 807 Subpart E, a manufacturer only has to show that their device is “substantially equivalent” to a “predicate” device already on the market. This is not the same as the rigorous Premarket Approval (PMA) process required for Class III life-sustaining devices.
The problem for women in Rowlett is a phenomenon known as “predicate creep.” For example, the manufacturer of GalaFLEX cited a surgical suture as a predicate device for a mesh scaffold. This allowed a material to be used in Rowlett breast surgeries without ever having been evaluated by the FDA for safety or effectiveness specifically in the breast tissue. In fact, on November 9, 2023, the FDA issued a letter to healthcare providers stating: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.”
Our firm, led by Ralph Manginello and Associate Attorney Lupe Peña, examines these regulatory failures closely. We look for evidence that manufacturers engaged in off-label promotion, encouraging Rowlett surgeons to use products in ways that were never validated. If you speak Spanish, Lupe Peña conducts full client consultations in fluent Spanish (hablamos español), ensuring every woman in the Rowlett community has access to this vital information. Reach out to us at 888-288-9911 for help.
Complications and Clinical Risks for the Rowlett Patient
When ADM or scaffolds are used in Rowlett, the risks range from aesthetic failure to life-threatening malignancies. Our legal team examines every pathology report and operative record to identify the specific failure mode that harmed you.
Red Breast Syndrome and Endotoxin Science
Rowlett patients using ADM frequently report “Red Breast Syndrome”—a noninfectious, sterile inflammation of the skin. Peer-reviewed literature, including studies by Nguyen et al. (2019), suggests this is caused by bacterial endotoxins (lipopolysaccharides) retained on the ADM through the sterilization process. While the device may be “sterile” in terms of live bacteria, the endotoxin remains biologically active, triggering a chronic inflammatory response in the Rowlett patient.
BIA-ALCL: Breast Implant-Associated Anaplastic Large Cell Lymphoma
One of the most serious risks associated with textured surfaces is BIA-ALCL. This is a CD30-positive, ALK-negative T-cell lymphoma classified by the World Health Organization as a distinct malignancy since 2016. In Rowlett, patients who received Allergan BIOCELL textured products were found to be at significantly higher risk, leading to the voluntary recall in July 2019. We are closely monitoring the Allergan BIOCELL MDL 2921 in the District of New Jersey, where the first bellwether trial is currently scheduled for October 19, 2026.
BIA-SCC: Emerging Squamous Cell Carcinoma Risks
The FDA issued a safety communication in September 2022 regarding BIA-SCC (Breast Implant-Associated Squamous Cell Carcinoma). This epithelial tumor is found in the implant capsule and can present anywhere from seven to forty-two years post-implantation. For a woman in Rowlett, a new lump, swelling, or skin change decades after surgery must be evaluated with this emerging literature in mind.
Reconstruction Failure and Systemic Illness
Other common complications seen in Rowlett include:
- Skin-Flap Necrosis: Death of the breast tissue due to compromised blood supply.
- Capsular Contracture (Baker Grade III/IV): Hardening of the scar tissue that deforms the breast.
- Breast Implant Illness (BII): Systemic symptoms like chronic fatigue, joint pain, and cognitive fog.
- Sepsis: A life-threatening systemic infection that can occur if a Rowlett patient’s device becomes colonized by a biofilm.
If you have experienced any of these, we believe you deserve answers. Contact Attorney911 at 1-888-ATTY-911 to discuss your Rowlett case.
High-Profile Litigation Capability: Why Rowlett Women Choose Attorney911
When fighting multi-billion-dollar medical device corporations, you need a firm with proven structural capability. We are currently lead counsel of record in Bermudez v. Pi Kappa Phi Fraternity, Inc., et al., seeking $10,000,000 in damages in Harris County (filed November 2025). This case, involving thirteen defendants and resulting in institutional shutdown at the University of Houston, demonstrates our ability to prosecute complex, multi-defendant liability litigation. We bring the same rigor to Rowlett defective device cases.
Managing Partner Ralph Manginello holds an Avvo Rating of 8.2 (Excellent) and a Martindale-Hubbell Preeminent 5.0 of 5.0 rating. Furthermore, he is a member of the Pro Bono College of the State Bar of Texas, a recognition for attorneys who far exceed the state’s pro bono goals. Our firm has earned a 4.9 of 5.0-star rating across hundreds of reviews on Birdeye, reflecting our commitment to the individuals we represent.
When you call 888-ATTY-911, you aren’t just getting a lawyer; you are getting a team with the technical command to challenge the manufacturer’s defense. We are admitted to the United States District Court for the Southern District of Texas, and we maintain an active national footprint in federal litigation.
Legal Theories for Rowlett Recovery: Strict Liability and Negligence
In Rowlett, and across Texas, product liability claims generally fall into three categories:
- Design Defect: The device was inherently dangerous as designed (e.g., the textured surface of a BIOCELL implant or the hydrolysis rate of a P4HB scaffold).
- Manufacturing Defect: A specific lot of ADM was contaminated with endotoxins during processing.
- Failure to Warn: The manufacturer provided inadequate warnings to Rowlett surgeons regarding the complication rates of products like FlexHD or AlloMax.
We also examine Off-Label Promotion. While surgeons may use products off-label, manufacturers are prohibited from marketing them for unapproved uses. If a sales representative in a Rowlett operating room encouraged a surgeon to use GalaFLEX Lite in a way the FDA didn’t clear, that manufacturer may be liable.
The Riegel v. Medtronic Exception
While Class III devices often enjoy “express preemption” under Riegel v. Medtronic (552 U.S. 312), most mesh and ADM products used in Rowlett were cleared via the 510(k) pathway. Under Medtronic v. Lohr (518 U.S. 470), these claims are generally not preempted, meaning Rowlett patients can still seek justice in state and federal courts.
The Rowlett Patient’s Path Forward: Venue and Statutes of Limitation
If you reside in Rowlett, your case will likely be filed in the U.S. District Court for the Northern District of Texas, Dallas Division, or in the state district courts of Dallas County. The statute of limitations in Texas for personal injury and product liability is generally two years from the date of injury. However, the “discovery rule” may apply. Many women in Rowlett did not realize their device was “off-label” until the FDA’s late-2023 warning. This may extend the time you have to file, but you must act quickly to preserve evidence.
Evidence Preservation for Rowlett Residents
If you are undergoing revision surgery in Rowlett, it is critical to:
- Request the Explanted Device: Do not let the hospital destroy the mesh, ADM, or scaffold.
- Secure Implant Stickers: Hospitals must retain Unique Device Identifiers (UDI). We can help you retrieve these.
- Request Pathology Slides: If BIA-ALCL or BIA-SCC is suspected, the physical slides are vital evidence.
Frequently Asked Questions for Rowlett Patients
Is GalaFLEX approved for breast surgery?
No. The FDA specifically noted in November 2023 that GalaFLEX and other BD mesh products have not been cleared or approved for breast procedures.
What if my Rowlett surgeon said the device was safe?
Surgeons often rely on the information provided by manufacturers. If the manufacturer withheld safety data—as alleged in whistleblower records—the liability remains with the device maker.
How do I find out what brand of mesh I have?
We can assist Rowlett patients in requesting a “certified complete” medical record, including the operative report and the implant log, which contains the brand and lot number.
Is there a cost to start a case at Attorney911?
No. We work on a contingency-fee basis. We pay all upfront costs of litigation, and you pay us nothing unless we recover compensation for you.
Why Rowlett Chooses Attorney911
We aren’t just a general personal injury firm. We understand the specific materials science of P4HB hydrolysis and the pathology of CD30+ lymphomas. Ralph Manginello or Lupe Peña will handle your case with the technical depth required to win.
We serve families throughout the Rowlett area, from the shores of Lake Ray Hubbard to the neighborhoods near Dalrock Road and Rowlett Road. We know the local medical infrastructure, including Baylor Scott & White Medical Center – Rowlett and the specialist centers across the DFW Metroplex.
If you are a breast cancer survivor, a BRCA mutation previvor, or a cosmetic revision patient in Rowlett, your well-being is our priority. We offer a safe, confidential space to discuss the trauma you’ve endured.
Contact Our Rowlett Injury Team Today
The time to begin documenting your claim is now. Whether you are facing a new diagnosis of BIA-ALCL or the frustration of a failed reconstruction in Rowlett, we are ready to stand with you. Reach out to Ralph Manginello and the team at Attorney911 for a free, no-obligation consultation.
Call us at 1-888-ATTY-911 (1-888-288-9911) or visit our website at attorney911.com to start your recovery today.
Si ha sido lesionada por una malla mamaria defectuosa en Rowlett, Lupe Peña está disponible para una consulta gratuita en español. Usted merece justicia y estamos aquí para luchar por usted.
Firm Credentials & E-E-A-T Signals:
- Ralph Manginello: Licensed State Bar of Texas No. 24007597 (27 Years Experience). Admitted to U.S. District Court, Southern District of Texas.
- Lupe Peña: Associate Attorney. Fluent Spanish consultations. Insurance defense background.
- Active Litigation: Lead counsel in Bermudez v. Pi Kappa Phi (Harris Co, 2025).
- Ratings: Avvo 8.2 Excellent; Martindale-Hubbell Preeminent 5.0. 4.9 Birdeye Rating across 200+ reviews.
- Podcast: Listen to the Attorney 911 podcast on Apple Podcasts (ID 1773141988) for in-depth legal education.
Rowlett Patient Resources & Support:
- American Cancer Society: 1-800-227-2345 (National support for Rowlett survivors).
- Susan G. Komen Breast Care Helpline: 1-877-465-6636.
- PROFILE Registry: Report BIA-ALCL cases at ThePSF.org/PROFILE.
- National Breast Cancer Foundation: nationalbreastcancer.org (Bilingual navigation available).
Every piece of information we provide is for educational purposes and does not constitute legal advice until an attorney-client relationship is formally established. No results are guaranteed; every case is unique. We fight aggressively for every client we represent in Rowlett and beyond.
